ArticleGlia2026
Single-Cell Integration of Mouse Models of Autism Reveals Conserved Transcriptomic Signatures of Excitatory-Inhibitory Imbalance and Glial Dysfunction.
Article in Glia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The etiological heterogeneity of autism spectrum disorder (ASD) complicates identifying core molecular mechanisms. We systematically integrated scRNA-seq data from 11 diverse genetic and environmental mouse (Mus musculus) models, encompassing > 300,000 cells across multiple brain regions and developmental stages. Using advanced computational harmonization (RPCA), we identified robust convergent transcriptomic signatures that transcend model-specific variability. Our findings reveal widespread alterations in neuronal communication pathways, specifically increased excitatory-inhibitory signaling involving PTN, SLIT, and PTPR pathways. Furthermore, cell-cell communication analysis via NicheNet prioritized ligand-receptor pairs associated with altered circuit excitability, offering a predictive blueprint of dysregulated intercellular crosstalk. Crucially, we identified significant glial involvement characterized by astrocyte function inhibition, marked by Aqp4 and Kcnj10 downregulation related to impaired water/potassium homeostasis and mature oligodendrocyte metabolic dysregulation through Olig family upregulation and enhanced oxidative phosphorylation. Differentially expressed genes (DEGs) significantly overlapped with SFARI-listed high-confidence risk genes, particularly within excitatory neuronal subtypes. Comparison with human postmortem single-nucleus data from the prefrontal and parietal cortices demonstrated conserved signatures related to impaired synaptic protein synthesis (GRIN2B, CAMK2A) and oligodendrocyte-mediated neurodevelopmental deficits (NRXN, DLGAP). This study confirms that E/I imbalance and glial dysfunction are universal cellular pathologies in ASD, providing a robust, large-scale reference for identifying novel therapeutic targets with single-cell resolution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.